Crisaborole 2% ointment as an effective and safe option in mild to moderate atopic dermatitis: data from a pilot study

Abheek Sil, Rashmi Sarkar, Bartika Sikder, Anupam Das

Open source

DOI
10.1093/ced/llae534
Published
2024-12-09
Container
Clinical and Experimental Dermatology
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ced/llae534,
  title = {Crisaborole 2\% ointment as an effective and safe option in mild to moderate atopic dermatitis: data from a pilot study},
  author = {Abheek Sil and Rashmi Sarkar and Bartika Sikder and Anupam Das},
  year = {2024},
  journal = {Clinical and Experimental Dermatology},
  doi = {10.1093/ced/llae534},
  url = {https://doi.org/10.1093/ced/llae534}
}

RIS

TY  - JOUR
TI  - Crisaborole 2% ointment as an effective and safe option in mild to moderate atopic dermatitis: data from a pilot study
AU  - Abheek Sil
AU  - Rashmi Sarkar
AU  - Bartika Sikder
AU  - Anupam Das
PY  - 2024
JO  - Clinical and Experimental Dermatology
DO  - 10.1093/ced/llae534
UR  - https://doi.org/10.1093/ced/llae534
ER  - 

APA

Sil, A., Sarkar, R., Sikder, B., & Das, A. (2024). Crisaborole 2% ointment as an effective and safe option in mild to moderate atopic dermatitis: data from a pilot study. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llae534

Source records